Inpatient Rehabilitation: Prediction of Changes in Sensorimotor Performance in Multiple Sclerosis: A Pilot Study

por Gulde, Philipp, Hermsdörfer, Joachim, Rieckmann, Peter
Publicado no J Clin Med (2021)

Speed but Not Smoothness of Gait Reacts to Rehabilitation in Multiple Sclerosis

por Gulde, Philipp, Hermsdörfer, Joachim, Rieckmann, Peter
Publicado no Mult Scler Int (2021)

UM 9(5)h and UM 9(5)p, human and porcine noncoding transcripts with preferential expression in the cerebellum.

por Michel, Uwe, Kallmann, Boris, Rieckmann, Peter, Isbrandt, Dirk
Publicado em 2002

Escalating Immunotherapy of Multiple Sclerosis

por Rieckmann, Peter, Traboulsee, Anthony, Devonshire, Virginia, Oger, Joel
Publicado em 2008

The Changes of P-glycoprotein Activity by Interferon-γ and Tumor Necrosis Factor-α in Primary and Immortalized Human Brain Microvascular Endothelial Cells

por Lee, Na-Young, Rieckmann, Peter, Kang, Young-Sook
Publicado em 2012

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis

por Metz, Imke, Rieckmann, Peter, Kallmann, Boris-Alexander, Brück, Wolfgang
Publicado no Acta Neuropathol Commun (2016)

Patient Power Revolution in Multiple Sclerosis: Navigating the New Frontier

por Yeandle, David, Rieckmann, Peter, Giovannoni, Gavin, Alexandri, Nektaria, Langdon, Dawn
Publicado no Neurol Ther (2018)

SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties

por Alkabie, Samir, Basivireddy, Jayasree, Zhou, Lixin, Roskams, Jane, Rieckmann, Peter, Quandt, Jacqueline A.
Publicado no J Neuroinflammation (2016)

Excitability decreasing central motor plasticity is retained in multiple sclerosis patients

por Zeller Daniel, Dang Su-Yin, Weise David, Rieckmann Peter, Toyka Klaus V, Classen Joseph
Publicado em 2012-09-01

Excitability decreasing central motor plasticity is retained in multiple sclerosis patients

por Zeller, Daniel, Dang, Su-Yin, Weise, David, Rieckmann, Peter, Toyka, Klaus V, Classen, Joseph
Publicado em 2012

Multiple sclerosis in the Arabian Gulf countries: a consensus statement

por Bohlega, Saeed, Inshasi, Jihad, Al Tahan, Abdel Rahman, Madani, Abu Bakr, Qahtani, Hussien, Rieckmann, Peter
Publicado em 2013

Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing m...

por Rieckmann, Peter, Heidenreich, Fedor, Sailer, Michael, Zettl, Uwe K., Zessack, Norbert, Hartung, Hans-Peter, Gold, Ralf
Publicado em 2012

Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26)

por Vordermark, Dirk, Ruprecht, Klemens, Rieckmann, Peter, Roggendorf, Wolfgang, Vince, Giles H, Warmuth-Metz, Monika, Kölbl, Oliver, Flentje, Michael
Publicado em 2006

Multiple Sclerosis Registry in Germany: Results of the Extension Phase 2005/2006

por Flachenecker, Peter, Stuke, Kristin, Elias, Wolfgang, Freidel, Matthias, Haas, Judith, Pitschnau-Michel, Dorothea, Schimrigk, Sebastian, Zettl, Uwe K., Rieckmann, Peter
Publicado em 2008

Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study

por Giovannoni, Gavin, Soelberg Sorensen, Per, Cook, Stuart, Rammohan, Kottil W, Rieckmann, Peter, Comi, Giancarlo, Dangond, Fernando, Hicking, Christine, Vermersch, Patrick
Publicado no Mult Scler (2018)

Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown

por Haarmann, Axel, Deiß, Annika, Prochaska, Jürgen, Foerch, Christian, Weksler, Babette, Romero, Ignacio, Couraud, Pierre-Olivier, Stoll, Guido, Rieckmann, Peter, Buttmann, Mathias
Publicado em 2010

Expert opinion on the use of cladribine tablets in clinical practice

por Sørensen, Per Soelberg, Centonze, Diego, Giovannoni, Gavin, Montalban, Xavier, Selchen, Daniel, Vermersch, Patrick, Wiendl, Heinz, Yamout, Bassem, Salloukh, Hashem, Rieckmann, Peter
Publicado no Ther Adv Neurol Disord (2020)

Downregulation of CXCR1 and CXCR2 Expression on Human Neutrophils by Helicobacter pylori: a New Pathomechanism in H. pylori Infection?

por Schmausser, Bernd, Josenhans, Christine, Endrich, Simon, Suerbaum, Sebastian, Sitaru, Cassian, Andrulis, Mindaugas, Brändlein, Stephanie, Rieckmann, Peter, Müller-Hermelink, Hans Konrad, Eck, Matthias
Publicado em 2004

Future MS care: a consensus statement of the MS in the 21st Century Steering Group

por Rieckmann, Peter, Boyko, Alexey, Centonze, Diego, Coles, Alasdair, Elovaara, Irina, Havrdová, Eva, Hommes, Otto, LeLorier, Jacques, Morrow, Sarah A., Oreja-Guevara, Celia, Rijke, Nick, Schippling, Sven
Publicado em 2012

Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries

por Aljumah, Mohammed, Alroughani, Raed, Alsharoqi, I., Bohlega, Saeed A., Dahdaleh, Maurice, Deleu, Dirk, Esmat, Khaled, Khalifa, Ahmad, Sahraian, Mohammad A., Szólics, Miklós, AlTahan, Abdulrahman, Yamout, Bassem I., Rieckmann, Peter, Daif, Abdulkader
Publicado em 2013